Latest Breaking News On - Tasly pharma - Page 1 : comparemela.com

Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer

Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer
optics.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from optics.org Daily Mail and Mail on Sunday newspapers.

United statesFrance generalMauna keaNicolas bouvierSacha loiseauChristopherd mcfaddenTasly pharmaTelix pharmaceuticalsRemuneration committeeMauna kea technologiesChief executive officerMauna kea technologies boardBoard memberTarget labsMauna kea technologies chairmanSeqone genomics

Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer

Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform

France generalMauna keaMauna kea technologieNicolas bouvierChristopherd mcfaddenTasly pharmaThomas grojeanMauna kea techonologieSacha loiseauTelix pharmaceuticalsRemuneration committeeRegulatory newsKea technologiesMauna kea technologiesChief executive officerMauna kea technologies board

Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer

Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalMauna keaMauna kea technologieNicolas bouvierChristopherd mcfaddenTasly pharmaThomas grojeanMauna kea techonologieSacha loiseauTelix pharmaceuticalsRemuneration committeeKea technologiesMauna kea technologiesChief executive officerMauna kea technologies boardBoard member

Week In Review: Qiming Closes $3 2 Billion For China Healthcare And Technology Investments

Qiming Venture Partners closed two new China healthcare and technology funds with $3.2 billion in fresh capital, both of them at their hard cap limits. Read more here.

Hong kongUnited statesStanley qiMauna keaCstone pharmaMauna kea cellvizioTasly pharmaGuangzhou bio thera solutionsLife sciencesGoldman sachsHong kong exchangeVenture partnersSouth san franciscoHorizon venturesGene expression modulation systemMauna kea technologies